Avicenna.AI offers a deep-learning radiology screening platform trained on CT imagery to help triage patients by identifying, detecting and quantifying critical pathologies. The product has two variants: one for brain trauma and stroke-risk assessment and another for chest-symptom evaluation. Its software classifies severity to help radiologists determine if a patient's life is at risk, supporting—but not replacing—clinical decision making. The platform has been deployed across Europe, the US and Asia, with more than 140 hospitals in 14 countries having purchased it. The company obtained its first patents and plans to extend its emergency suite and broader portfolio. Management aims to scale deployments, targeting at least 30 new medical sites per month in 2023.

Total raised

$8M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2023